Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

SONN

Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SONN
일자시간출처헤드라인심볼기업
2025/02/1406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/1322:30GlobeNewswire Inc.Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business OfficerNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/1322:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/1322:00GlobeNewswire Inc.Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings UpdateNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/0314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/0314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/0106:57Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/02/0106:56Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/3107:25Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/3107:25Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2823:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2823:05GlobeNewswire Inc.Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform TechnologyNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2306:15Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2306:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2222:35GlobeNewswire Inc.Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment WebinarNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2214:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2123:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2123:05GlobeNewswire Inc.Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain SarcomasNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/2122:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2025/01/1406:34Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/2406:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/2323:20GlobeNewswire Inc.Sonnet BioTherapeutics Announces Release of the Next CEO Corner SegmentNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/1723:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/1722:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/1722:50GlobeNewswire Inc.Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/1023:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/1023:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/1005:42GlobeNewswire Inc.Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/0922:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
2024/12/0922:45GlobeNewswire Inc.Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 TrialNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
 검색 관련기사 보기:NASDAQ:SONN

최근 히스토리

Delayed Upgrade Clock